Protalix BioTherapeutics (DE) (PLX) News
NYSE: PLXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
PLX news summary
We found 6 recent headlines mentioning Protalix BioTherapeutics (DE) (PLX): 0 in the past week and 6 in the past 30 days, most often from GlobeNewswire, Nasdaq, PR Newswire. PLX is making an outsized move today, down 5.23% at $2.90, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Protalix BioTherapeutics Inc. Q3 Income Advances", was published by Nasdaq on Nov 10, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Protalix BioTherapeutics (DE) headlines
- Protalix BioTherapeutics Inc. Q3 Income Advances(RTTNews) - Protalix BioTherapeutics Inc. (PLX) released a profit for its third quarter that Increased, from the same period last yearNasdaq
- Pluxee convoque son Assemblée générale annuelle d’actionnaires pour l’exercice 2026Pluxee convoque son Assemblée générale annuelle d’actionnaires pour l’exercice 2026GlobeNewswire
- Pluxee convenes its Fiscal 2026 Annual General Meeting of ShareholdersPluxee convenes its Fiscal 2026 Annual General Meeting of ShareholdersGlobeNewswire
- Protalix BioTherapeutics to Announce Third Quarter 2026 Financial Results and Business Update on November 10, 2026Company to host conference call and webcast at 8:00 a.m. ET CARMIEL, Israel, Nov. 3, 2026 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on…PR Newswire
- Pluxee dépasse l'ensemble de ses objectifs financiers pour l’exercice 2026 et se prépare activement à une nouvelle phase de croissance rentablePluxee dépasse l'ensemble de ses objectifs financiers pour l’exercice 2026 et se prépare activement à une nouvelle phase de croissance rentableGlobeNewswire
- Pluxee delivered above all Fiscal 2026 financial objectives and is gearing up for its next phase of profitable growthPluxee delivered above all Fiscal 2026 financial objectives and is gearing up for its next phase of profitable growthGlobeNewswire